Lawrence Serfaty

Lawrence Serfaty

Auto-generated profile, based on publicly available information

Lawrence Serfaty

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, F-75012 Paris, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Hepatology
Verified
Journal Article
Closed access
ONOumarou Nabi
Oumarou Nabi
NLNathanael Lapidus
Nathanael Lapidus
JBJerome Boursier
Jerome Boursier
VLVictor de Ledinghen
Victor de Ledinghen
JPJean-Michel Petit
Jean-Michel Petit
LSLawrence Serfaty
Lawrence Serfaty
Background and Aims: The severity of liver injury and clinical outcomes in lean individuals with NAFLD is a subject of debate and very few studies have been performed in the general population. The aim of this study was to compare subject characteristics and mortality between lean and nonlean NAFLD in a community setting. Approach and Results: The study population included 169,303 participants from the nationwide Constances cohort. Subjects with excessive alcohol consumption, viral hepatitis, or other liver diseases were excluded and 137,206 subjects were analyzed. The diagnosis of NAFLD and fibrosis was performed using the Fatty Liver Index and the Forns Index. The median follow-up was 3.58 years. The prevalence of NAFLD was 5.3% (95% CI: 5.2–5.4) in lean subjects, while 16.3% (95% CI: 15.7–16.8) of NAFLD subjects were lean. Despite their better metabolic profile, the prevalence of advanced fibrosis was significantly higher in lean than in nonlean NAFLD (3.7% vs. 1.7%, respectively, p < 0.01). Among NAFLD subjects and after adjustment for demographics, metabolic risk factors and lifestyle, lean status was associated with advanced fibrosis (OR=1.26, 95% CI: 1.20–1.65, p = 0.005), an increased risk of liver-related events (adjusted HR=5.84, 95% CI: 4.03–8.46), chronic kidney disease (adjusted HR=2.49, 95% CI: 1.49–4.16), and overall mortality (adjusted HR=3.01, 95% CI: 2.21–4.11). Liver-related events and overall mortality were related to the severity of fibrosis, both in lean and nonlean NAFLD subjects, whatever the usual risk factors. Conclusion: This study in a large community-based cohort confirms that NAFLD in lean subjects is more severe for fibrosis, the progression of liver disease, chronic kidney disease, and overall mortality.

1 August 2020 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
ONOumarou Nabi
Oumarou Nabi
KLKarine Lacombe
Karine Lacombe
JBJérôme Boursier
Jérôme Boursier
PMPhilippe Mathurin
Philippe Mathurin
MZMarie Zins
Marie Zins
LSLawrence Serfaty
Lawrence Serfaty

8 June 2022 in Hepatology
Verified
Journal Article
Open access
CACoralie Amadou
Coralie Amadou
ONOumarou Nabi
Oumarou Nabi
LSLawrence Serfaty
Lawrence Serfaty
KLKarine Lacombe
Karine Lacombe
JBJérôme Boursier
Jérôme Boursier
MCMarie‐Aline Charles
Marie‐Aline Charles
Background and Aims: The association between birth weight (BW) and metabolic outcomes has been described since the 1980s but NAFLD has been rarely studied. This study aimed to investigate the association between BW and NAFLD occurrence in adult subjects. Approach and Results: The study population consisted of participants from the French nationwide Constances cohort from 2012 to 2019. Participants with a history of chronic viral hepatitis or excessive alcohol consumption were excluded. Noninvasive diagnosis of NAFLD and fibrosis was performed using a combination of the Fatty Liver Index (FLI) and the Forns Index. The relationship between BW and NAFLD was analyzed with a sex‐stratified logistic regression model adjusted for sociodemographic parameters, lifestyle, and birth term, whereas liver fibrosis was analyzed with a sex‐stratified linear regression model. In total, 55,034 individuals with reliable BW were included (43% men, mean age: 38 years). NAFLD (FLI ≥ 60) was present in 5530 individuals (10%). Multivariate logistic regression showed a significant U‐shaped relationship between BW and NAFLD, with no significant interaction with sex. A significant and slightly decreasing association was found between BW and Forns Index (β = −0.05; p = 0.04). Premature birth (OR, 1.23; 95% CI, 1.03–1.48 for birth between 33 and 37 weeks versus ≥ 37 weeks) was associated with NAFLD, with a significant direct effect of premature birth, and without an indirect effect of low BW in mediation analysis. Forns Index was not significantly higher in participants with preterm birth compared to full‐term birth. Conclusions: This large prospective adult‐based cohort confirms the relationship between BW and NAFLD occurrence.

10 February 2018 in Liver International
Verified
Journal Article
Closed access
PDF file
LSLawrence Serfaty
Lawrence Serfaty

1 July 2013 in Journal of Hepatology
Verified
Journal Article
Closed access
ELEric Lawitz
Eric Lawitz
MRMaribel Rodriguez-Torres
Maribel Rodriguez-Torres
ASAlbrecht Stoehr
Albrecht Stoehr
EGEdward J. Gane
Edward J. Gane
LSLawrence Serfaty
Lawrence Serfaty
NMNiloufar Mobashery
Niloufar Mobashery

24 May 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
ONOumarou Nabi
Oumarou Nabi
JBJerome Boursier
Jerome Boursier
KLKarine Lacombe
Karine Lacombe
PMPhilippe Mathurin
Philippe Mathurin
VLVictor de Ledinghen
Victor de Ledinghen
LSLawrence Serfaty
Lawrence Serfaty